Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Tumor Necrosis Factor Drugs”

23 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 23 results

Post-approval studies (Phase 4)Study completedNCT01593332
What this trial is testing

Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis

Who this might be right for
DMARD Resistant Rheumatoid Arthritis
Mashhad University of Medical Sciences 44
Not applicableUnknownNCT02116504
What this trial is testing

Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients

Who this might be right for
Rheumatoid ArthritisJuvenile Idiopathic Arthritis
Assistance Publique - Hôpitaux de Paris 156
Not applicableStudy completedNCT03090139
What this trial is testing

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets

Who this might be right for
Colitis, UlcerativeCrohn DiseaseInflammatory Bowel Diseases
Takeda 1,731
Post-approval studies (Phase 4)Study completedNCT04953871
What this trial is testing

Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis

Who this might be right for
SpondyloarthritisEnthesitisAnti-Tumor Necrosis Factor Drugs
Gunay ER 31
Not applicableStudy completedNCT02508012
What this trial is testing

Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases

Who this might be right for
Crohn's DiseaseUlcerative Colitis
University Hospital, Montpellier 260
Post-approval studies (Phase 4)UnknownNCT02186886
What this trial is testing

Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab

Who this might be right for
Ulcerative Colitis
Kliniken im Naturpark Altmuehltal 50
Not applicableStudy completedNCT03348046
What this trial is testing

Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan

Who this might be right for
Rheumatoid Arthritis
Hikma Pharmaceuticals LLC 22
Not applicableStudy completedNCT01362062
What this trial is testing

Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 110
Large-scale testing (Phase 3)Study completedNCT00048581
What this trial is testing

Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 738
Not applicableStudy completedNCT02073526
What this trial is testing

Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Oslo University Hospital 1,230
Not applicableStudy completedNCT00000860
What this trial is testing

The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients

Who this might be right for
Mycobacterium Avium-Intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Large-scale testing (Phase 3)Ended earlyNCT01230827
What this trial is testing

The Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)

Who this might be right for
Juvenile Idiopathic Arthritis
Janssen Research & Development, LLC 173
Testing effectiveness (Phase 2)UnknownNCT00855322
What this trial is testing

Study Examining the Effect of Exercise in People With Rheumatoid Arthritis Taking Anti-TNFalpha Medication

Who this might be right for
Arthritis, Rheumatoid
University College Dublin 51
Not applicableStudy completedNCT00768950
What this trial is testing

The Characterization of Small Bowel and Colonic Involvement in Patients With Seronegative Spondyloarthritides

Who this might be right for
Spondyloarthropathies
Carol Davila University of Medicine and Pharmacy 65
Not applicableStudy completedNCT05447182
What this trial is testing

People-Powered Medicine (PPM): Rheumatoid Arthritis Non-responders to Biologic Therapies (RANT)

Who this might be right for
Rheumatoid Arthritis
Brigham and Women's Hospital 300
Not applicableStudy completedNCT03452501
What this trial is testing

Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients

Who this might be right for
Inflammatory Bowel DiseasesCrohn DiseaseFistulizing Crohn's Disease+1 more
Hikma Pharmaceuticals LLC 157
Testing effectiveness (Phase 2)Ended earlyNCT01037907
What this trial is testing

Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Boston Scientific Corporation 173
Early research (Phase 1)Not Yet RecruitingNCT06385522
What this trial is testing

A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System

Who this might be right for
NHLCutaneous T Cell LymphomaPeripheral T-cell Lymphoma
Boston Immune Technologies and Therapeutics 37
Not applicableLooking for participantsNCT07198113
What this trial is testing

COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)

Who this might be right for
Ulcerative Colitis, PediatricInflammatory Bowel DiseasesCrohn Disease
University of North Carolina, Chapel Hill 1,100
Testing effectiveness (Phase 2)Study completedNCT00135720
What this trial is testing

Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris

Who this might be right for
Pemphigus Vulgaris
Massachusetts General Hospital 12
Load More Results